India
· Delayed Price · Currency is INR Aarti Pharmalabs Statistics
Total Valuation
NSE:AARTIPHARM has a market cap or net worth of INR 66.40 billion. The enterprise value is 69.27 billion.
| Market Cap | 66.40B |
| Enterprise Value | 69.27B |
Important Dates
The next estimated earnings date is Monday, May 12, 2025.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | Feb 14, 2025 |
Share Statistics
NSE:AARTIPHARM has 90.63 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 90.63M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 29.23% |
| Owned by Institutions (%) | 20.52% |
| Float | 47.69M |
Valuation Ratios
The trailing PE ratio is 26.64.
| PE Ratio | 26.64 |
| Forward PE | n/a |
| PS Ratio | 3.23 |
| PB Ratio | 3.57 |
| P/TBV Ratio | 3.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 27.78 |
| EV / Sales | 3.37 |
| EV / EBITDA | 15.95 |
| EV / EBIT | 19.62 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 0.89 |
| Debt / FCF | n/a |
| Interest Coverage | 14.13 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.72% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 9.82M |
| Profits Per Employee | 1.19M |
| Employee Count | 2,095 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +58.22% in the last 52 weeks. The beta is -0.63, so NSE:AARTIPHARM's price volatility has been lower than the market average.
| Beta (5Y) | -0.63 |
| 52-Week Price Change | +58.22% |
| 50-Day Moving Average | 690.19 |
| 200-Day Moving Average | 641.33 |
| Relative Strength Index (RSI) | 51.65 |
| Average Volume (20 Days) | 673,560 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AARTIPHARM had revenue of INR 20.57 billion and earned 2.49 billion in profits. Earnings per share was 27.50.
| Revenue | 20.57B |
| Gross Profit | 9.15B |
| Operating Income | 3.53B |
| Pretax Income | 3.42B |
| Net Income | 2.49B |
| EBITDA | 4.34B |
| EBIT | 3.53B |
| Earnings Per Share (EPS) | 27.50 |
Balance Sheet
The company has 995.13 million in cash and 3.86 billion in debt, giving a net cash position of -2.87 billion or -31.66 per share.
| Cash & Cash Equivalents | 995.13M |
| Total Debt | 3.86B |
| Net Cash | -2.87B |
| Net Cash Per Share | -31.66 |
| Equity (Book Value) | 18.57B |
| Book Value Per Share | 204.97 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 44.47%, with operating and profit margins of 17.16% and 12.12%.
| Gross Margin | 44.47% |
| Operating Margin | 17.16% |
| Pretax Margin | 16.62% |
| Profit Margin | 12.12% |
| EBITDA Margin | 21.11% |
| EBIT Margin | 17.16% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 0.48%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 0.48% |
| Dividend Growth (YoY) | 75.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.46% |
| Earnings Yield | 3.75% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |